Literature DB >> 12675640

Absolute level and rate of change of albuminuria over 1 year independently predict mortality and cardiovascular events in patients with diabetic nephropathy.

M F Yuyun1, S F Dinneen, O M Edwards, E Wood, N J Wareham.   

Abstract

AIMS: To determine the nature of the association between baseline albuminuria and risk of all-cause mortality and cardiovascular disease, and to determine if the rate of change of albuminuria from baseline over 1 year predicts these endpoints in patients with diabetic nephropathy.
METHODS: Cohort study of 427 patients (161 Type 1 and 266 Type 2) with diabetic nephropathy defined as urinary albumin excretion (UAE) > or = 30 mg/24 h at baseline (mean age 53.4 years). Patients were recruited at the time of referral to a diabetic nephropathy clinic and followed up annually for an average of 5 years. UAE rate was re-measured at 1 year and the rate of change from baseline calculated.
RESULTS: All-cause mortality and cardiovascular disease increased significantly and continuously across quintiles of baseline UAE (P for linear trend < 0.001 in both outcomes). The rate of change of albuminuria over 1 year (log10) independently predicted all-cause mortality (hazard ratio (95% confidence interval) 1.76 (1.39, 3.11)) and cardiovascular mortality (1.57 (1.13, 5.22)). Taken as a categorical variable, a rate of change of albuminuria > or = 30% independently predicted mortality and cardiovascular events (2.07 (1.5, 4.30) and 1.89 (1.33, 4.06), respectively).
CONCLUSIONS: The rate of change of albuminuria over 1 year independently predicts mortality and cardiovascular disease in diabetic nephropathy and may have clinical utility as a risk marker in identifying a subgroup of patients at particular risk. The risk of these outcomes is continuous across the range of baseline albuminuria in patients with diabetic nephropathy.

Entities:  

Mesh:

Year:  2003        PMID: 12675640     DOI: 10.1046/j.1464-5491.2003.00940.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  13 in total

1.  Change in estimated GFR associates with coronary heart disease and mortality.

Authors:  Kunihiro Matsushita; Elizabeth Selvin; Lori D Bash; Nora Franceschini; Brad C Astor; Josef Coresh
Journal:  J Am Soc Nephrol       Date:  2009-11-05       Impact factor: 10.121

Review 2.  Podocytopathy in diabetes: a metabolic and endocrine disorder.

Authors:  Ana Diez-Sampedro; Oliver Lenz; Alessia Fornoni
Journal:  Am J Kidney Dis       Date:  2011-06-29       Impact factor: 8.860

3.  Albuminuria, Proteinuria, and Renal Disease Progression in Children with CKD.

Authors:  Dana Y Fuhrman; Michael F Schneider; Katherine M Dell; Tom D Blydt-Hansen; Robert Mak; Jeffrey M Saland; Susan L Furth; Bradley A Warady; Marva M Moxey-Mims; George J Schwartz
Journal:  Clin J Am Soc Nephrol       Date:  2017-05-25       Impact factor: 8.237

Review 4.  Recent advances in diabetic nephropathy.

Authors:  S M Marshall
Journal:  Postgrad Med J       Date:  2004-11       Impact factor: 2.401

5.  Fibrinogen and AER are major independent predictors of 11-year cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study.

Authors:  G Bruno; F Merletti; A Biggeri; G Bargero; S Ferrero; G Pagano; P Cavallo-Perin
Journal:  Diabetologia       Date:  2005-02-05       Impact factor: 10.122

6.  Mortality and morbidity in relation to changes in albuminuria, glucose status and systolic blood pressure: an analysis of the ONTARGET and TRANSCEND studies.

Authors:  Roland E Schmieder; Rudolph Schutte; Helmut Schumacher; Michael Böhm; Giuseppe Mancia; Michael A Weber; Matthew McQueen; Koon Teo; Salim Yusuf
Journal:  Diabetologia       Date:  2014-07-19       Impact factor: 10.122

Review 7.  Slowing nephropathy progression: focus on proteinuria reduction.

Authors:  George L Bakris
Journal:  Clin J Am Soc Nephrol       Date:  2008-01       Impact factor: 8.237

8.  Urinary biomarkers are associated with incident cardiovascular disease, all-cause mortality and deterioration of kidney function in type 2 diabetic patients with microalbuminuria.

Authors:  Bernt Johan von Scholten; Henrik Reinhard; Tine W Hansen; Jens Oellgaard; Hans-Henrik Parving; Peter K Jacobsen; Peter Rossing
Journal:  Diabetologia       Date:  2016-03-31       Impact factor: 10.122

9.  A prospective two-center study on the associations between microalbuminuria, coronary atherosclerosis and long-term clinical outcome in asymptomatic patients with type 2 diabetes mellitus: evaluation by coronary CT angiography.

Authors:  Jin-Jin Kim; Byung-Hee Hwang; Ik Jun Choi; Eun-Ho Choo; Sungmin Lim; Yoon-Seok Koh; Jong Min Lee; Pum-Joon Kim; Ki-Bae Seung; Seung-Hwan Lee; Jae-Hyung Cho; Jung Im Jung; Kiyuk Chang
Journal:  Int J Cardiovasc Imaging       Date:  2014-10-04       Impact factor: 2.357

Review 10.  Role of altered insulin signaling pathways in the pathogenesis of podocyte malfunction and microalbuminuria.

Authors:  Alexandra Jauregui; Daniel H Mintz; Peter Mundel; Alessia Fornoni
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-11       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.